![Nitya Ray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nitya Ray
Keine laufenden Positionen mehr
Profil
Nitya G.
Ray worked as a Director of Bioprocess Development at Forticell Bioscience, Inc. from 1997 to 2001.
He then worked at Progenics Pharmaceuticals, Inc. for 17 years, starting as a Senior Vice President of Manufacturing in 2001 and ending as an Executive Vice President in 2018.
In 2017, he briefly worked as an Executive Vice President at Actinium Pharmaceuticals, Inc. before becoming the Chief Technology Officer at CytoDyn, Inc. in 2018.
Dr. Ray received his undergraduate degree from Jadavpur University and his graduate and doctorate degrees from Rutgers State University of New Jersey.
Ehemalige bekannte Positionen von Nitya Ray
| Unternehmen | Position | Ende |
|---|---|---|
| CYTODYN INC. | Geschäftsführer | 19.04.2022 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21.12.2018 |
| PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2018 |
Forticell Bioscience, Inc.
 Forticell Bioscience, Inc. BiotechnologyHealth Technology Advances regenerative medicine through development of cellular technology & advanced biomaterial products | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Nitya Ray
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
44
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Advances regenerative medicine through development of cellular technology & advanced biomaterial products | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
CytoDyn, Inc.
 CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jadavpur University
 Jadavpur University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
